Re: New article on BET Inhibitors in Cardiovascular Disease
in response to
by
posted on
Jan 30, 2019 08:21PM
GAC is this report too good to be true? Might this be the first sign of a possible dreaded "pump" that you have warned us about so often? Hope not . . .
Not even close in my opinion...to my eyes it looks academic, not something generated by some promotional shop. In my experience articles designed to pump a stock, they always mention the fact that its a publicl company and the exchange(s) and symbol(s).
As for a pump being "dreaded"....I don't know that I "dread" pumps.
You'll recall that I tried to hook the company up with a promotional outfit, a Florida broadcast that's available via satellite on the Voice of America Biz channel. I forwarded a proposal that came direct from the Ellis Martin Report....to my way of thinking some promotion on the EMR would have been more cost effective in terms of attracting investor interest to Resverlogix than all the Bio type conferences Don keep presenting at.
If they'd gone ahead with it I was planning to sell some shares into the ensuing promotion, based on the belief that some hype would have driven up the PPS. The fact they weren't interested in that kind of exposure suggests to me that they're confident that Resverlogix can succeed on its merits without needing to be touted....the walk softly and carry a big stick kind of attitude.